140 related articles for article (PubMed ID: 8105062)
1. New pyrazolylhydrazone derivatives as inhibitors of platelet aggregation.
da Silveira IA; Paulo LG; de Miranda AL; Rocha SO; Freitas AC; Barreiro EJ
J Pharm Pharmacol; 1993 Jul; 45(7):646-9. PubMed ID: 8105062
[TBL] [Abstract][Full Text] [Related]
2. Substituted pyrazolylhydrazones: a new class of platelet aggregation inhibitors.
Silveira IA; Paulo LG; Miranda AL; Rocha SO; Freitas AC; Barreiro EJ
Braz J Med Biol Res; 1991; 24(9):947-51. PubMed ID: 1797291
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel indole hydrazone derivatives and evaluation of their antiplatelet aggregation activity.
Mashayekhi V; Haj Mohammad Ebrahim Tehrani K; Amidi S; Kobarfard F
Chem Pharm Bull (Tokyo); 2013; 61(2):144-50. PubMed ID: 23154304
[TBL] [Abstract][Full Text] [Related]
4. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
5. Effects of chroman derivatives on platelet aggregation induced by some aggregating agents in rabbits.
Aida Y; Kasama T; Fukaya H; Takeuchi N; Sugiyama K; Tobinaga S
Clin Exp Pharmacol Physiol; 1998 Nov; 25(11):939-44. PubMed ID: 9807668
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet properties of novel N-substituted-phenyl-1,2,3-triazole-4-acylhydrazone derivatives.
Cunha AC; Figueiredo JM; Tributino JL; Miranda AL; Castro HC; Zingali RB; Fraga CA; de Souza MC; Ferreira VF; Barreiro EJ
Bioorg Med Chem; 2003 May; 11(9):2051-9. PubMed ID: 12670656
[TBL] [Abstract][Full Text] [Related]
7. 2-Pyridylarylhydrazone derivatives, a new class of platelet aggregation inhibitors.
Todeschini AR; Miranda AL; Bacha CM; Barreiro EJ
Braz J Med Biol Res; 1996 Mar; 29(3):389-93. PubMed ID: 8736135
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets.
Lim H; Kubota K; Kobayashi A; Seki T; Ariga T
Biosci Biotechnol Biochem; 1999 Feb; 63(2):298-301. PubMed ID: 10192909
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of H2-receptor antagonists on platelet function in vitro.
Nakamura K; Kariyazono H; Shinkawa T; Yamaguchi T; Yamashita T; Ayukawa O; Moriyama Y; Yotsumoto G; Toyohira H; Taira A; Yamada K
Hum Exp Toxicol; 1999 Aug; 18(8):487-92. PubMed ID: 10462360
[TBL] [Abstract][Full Text] [Related]
10. N-substituted indole carbohydrazide derivatives: synthesis and evaluation of their antiplatelet aggregation activity.
Mirfazli SS; Kobarfard F; Firoozpour L; Asadipour A; Esfahanizadeh M; Tabib K; Shafiee A; Foroumadi A
Daru; 2014 Sep; 22(1):65. PubMed ID: 25238875
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, antiplatelet and antithrombotic activities of resveratrol derivatives with NO-donor properties.
Dutra LA; Guanaes JFO; Johmann N; Lopes Pires ME; Chin CM; Marcondes S; Dos Santos JL
Bioorg Med Chem Lett; 2017 Jun; 27(11):2450-2453. PubMed ID: 28400236
[TBL] [Abstract][Full Text] [Related]
12. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
Carter AJ; Heptinstall S
Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
[TBL] [Abstract][Full Text] [Related]
13. Pyridazines. XIII. Synthesis of 6-aryl-5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors.
Laguna R; Rodriguez-Liñares B; Cano E; Estevez I; Raviña E; Sotelo E
Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1151-5. PubMed ID: 9246748
[TBL] [Abstract][Full Text] [Related]
14. Rational Design and Synthesis of 1-(Arylideneamino)-4-aryl-1H-imidazole-2-amine Derivatives as Antiplatelet Agents.
Amidi S; Esfahanizadeh M; Tabib K; Soleimani Z; Kobarfard F
ChemMedChem; 2017 Jun; 12(12):962-971. PubMed ID: 28494138
[TBL] [Abstract][Full Text] [Related]
15. 4-(1H-pyrazol-1-yl)-2-butylamine derivatives as inhibitors of blood platelet aggregation.
Ferroni R; Milani L; Simoni D; Orlandini P; Guarneri M; Franzé D; Bardi A
Farmaco; 1989 May; 44(5):495-502. PubMed ID: 2506876
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis and antiplatelet activity of 2-amino-4,5-diphenylthiazole derivatives].
Inoue H; Ikesue K; Taniguchi Y
Yakugaku Zasshi; 1995 Aug; 115(8):603-10. PubMed ID: 7473057
[TBL] [Abstract][Full Text] [Related]
17. One pot synthesis and biological activity evaluation of novel Schiff bases derived from 2-hydrazinyl-1,3,4-thiadiazole.
Haj Mohammad Ebrahim Tehrani K; Sardari S; Mashayekhi V; Esfahani Zadeh M; Azerang P; Kobarfard F
Chem Pharm Bull (Tokyo); 2013; 61(2):160-6. PubMed ID: 23183543
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives.
Ferrarini PL; Badawneh M; Franconi F; Manera C; Miceli M; Mori C; Saccomanni G
Farmaco; 2001 Apr; 56(4):311-8. PubMed ID: 11421260
[TBL] [Abstract][Full Text] [Related]
19. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-platelet activity of obovatol derivatives.
Kwak JH; Lee S; Park ES; In JK; Song J; Kim YJ; Choi NS; Lee H; Yun YP; Hong JT; Kwak YS; Min KH; Jung JK
Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
